研究发现,CDKN2A基因能够根据突变时间防止或促进食道癌。 Study finds gene CDKN2A can prevent or promote esophageal cancer based on mutation timing.

由英国癌症研究资助的一项新研究表明,基因CDKN2A既能预防和促进食道癌,又取决于其突变的时机。 A new study funded by Cancer Research UK reveals that the gene CDKN2A can both prevent and promote esophageal cancer, depending on the timing of its mutation. 这一发现在《自然癌症》中发表,表明CDKN2A早期突变,没有伴随的第53页突变,可能表明癌症发作的风险较低。 This discovery, published in Nature Cancer, indicates that early mutations in CDKN2A without accompanying p53 mutations may suggest a lower risk of cancer progression. 研究结果可导致更个性化的癌症风险评估和预防战略。 The findings could lead to more personalized cancer risk assessment and prevention strategies.